Ketamine News — Latest Ketamine Therapy News & Research
Ketamine Maintenance Planning: Relapse, Reassessment, and Stopping Decisions
Ketamine News Editorial Team · October 30, 2026
Read storyNews & insights
Urinary Symptoms During Ketamine Care: What to Report and What Remains Uncertain
By Ketamine News Editorial Team · October 30, 2026
Dissociation During Ketamine: Why Intensity Is Not a Treatment Score
By Ketamine News Editorial Team
Medication Reconciliation Before Ketamine: Making the Full List Useful
By Ketamine News Editorial Team
Blood Pressure and Ketamine Care: Understanding the Safety Conversation
By Ketamine News Editorial Team
Ketamine Maintenance Planning: Relapse, Reassessment, and Stopping Decisions
By Ketamine News Editorial Team
Building a Ketamine Treatment Record: What to Track Beyond a Mood Score
By Ketamine News Editorial Team
Spravato Without an Oral Antidepressant: What Monotherapy Means for Patients
By Ketamine News
Editor's picks
Ketamine Maintenance Planning: Relapse, Reassessment, and Stopping Decisions
October 30, 2026
Building a Ketamine Treatment Record: What to Track Beyond a Mood Score
October 30, 2026
Capturing the Ketamine Experience in Real Time: A First-of-its-Kind Academic Paper from Denovo Therapy
May 8, 2024
A Group of D.C. Advocacy Groups Have Joined Hands to Push For Drug Policy Reform in the Nation’s Capital
April 26, 2024
Latest headlines
Ketamine Safety and Informed Consent: A Guide to Evaluating a Care Setting
October 30, 2026
Read the full storyIndependent reporting on ketamine therapy, research and care
Ketamine News is an independent publication covering ketamine therapy for mental health and pain. We report on clinical research, FDA-approved esketamine (Spravato), ketamine infusion clinics, and what patients can realistically expect from treatment.
Our coverage spans ketamine for depression, including treatment-resistant depression, along with ketamine for anxiety, PTSD and chronic pain. New to the terms? Start with our Ketamine Dictionary or explore esketamine coverage. Articles are educational and are not a substitute for advice from a licensed clinician.
Latest News
Ketamine Safety and Informed Consent: A Guide to Evaluating a Care Setting
A Decision Guide for a Ketamine Consultation: Evidence, Alternatives, and Goals
Ketamine Treatment Logistics: Planning Work, Transport, and Support
Reading Ketamine Response Rates: Denominators, Comparators, and Follow-Up
Urinary Symptoms During Ketamine Care: What to Report and What Remains Uncertain
Dissociation During Ketamine: Why Intensity Is Not a Treatment Score
Medication Reconciliation Before Ketamine: Making the Full List Useful
Blood Pressure and Ketamine Care: Understanding the Safety Conversation
Spravato Without an Oral Antidepressant: What Monotherapy Means for Patients
Your First Spravato Appointment: Planning for Monitoring, Recovery, and the Ride Home
Esketamine, Ketamine, and Compounded Products: How to Read the Differences
Ketamine and Suicidal Thoughts: Why Symptom Relief Is Not the Same as Suicide Prevention
Oral Ketamine for Chronic Pain: Questions to Ask Before Trying It
FDA Expands Spravato Label to Allow Standalone Treatment for Resistant Depression
2025 Randomized Trial Tests Esketamine as a Standalone Depression Treatment
2025 Review Finds a Key Gap in Ketamine Research: Suicidal Behavior Outcomes
Oral Ketamine for PTSD: 2025 Pilot Study Offers an Early Signal, Not a Final Answer
2025 Pain Reviews Find Oral Ketamine Evidence Depends on the Clinical Setting
Ketamine Decoded: New Study Sheds Light on Its Powerful Brain and Mood Effects
Latest Insights
Ketamine News Editorial Team · October 30, 2026